Patents Assigned to Chengdu Anticancer Bioscience, Ltd.
  • Cancer treatment using compounds that selectively target polyploid cancer cells for disruption
    Patent number: 11104633
    Abstract: The disclosure provides a compound of Formula I: or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, and R4 are as described herein. The disclosure also provides methods for identifying a compound that selectively kills polyploid cells, and methods for killing polyploid tumor cells by administering a compound of Formula I to a patient in need thereof.
    Type: Grant
    Filed: May 21, 2018
    Date of Patent: August 31, 2021
    Assignee: Chengdu Anticancer Bioscience, Ltd.
    Inventors: Dun Yang, Jing Zhang, Shenqiu Zhang